Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 Sep;108(6):801-2.
doi: 10.1172/JCI14003.

Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?

M J Robertson  1
Affiliations
Review

Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?

M J Robertson. J Clin Invest. 2001 Sep.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000;343:481–492. - PubMed
    1. Purtilo DT, Strobach RS, Okano M, Davis JR. Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest. 1992;67:5–23. - PubMed
    1. Knowles DM, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 1995;85:552–565. - PubMed
    1. Orazi A, et al. Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features. Am J Clin Pathol. 1997;107:419–429. - PubMed
    1. Mamzer-Bruneel M-F, et al. Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: a report of 16 cases observed in a single center. J Clin Oncol. 2000;18:3622–3632. - PubMed

MeSH terms

Substances